Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04634604 · ClinicalTrials.gov registry record · Phase 3
A Randomized Trial of Low-Dose Bevacizumab vs Laser for Type 1 ROP
A Phase 3 study, sponsored by Jaeb Center for Health Research.
- Terminated
- Registry status
- Phase 3
- Development phase
- 16
- Enrollment target
NCT04634604 is a Phase 3 study that was terminated before completion, run by Jaeb Center for Health Research. The registered enrollment target is 16 participants.
The verdict
NCT04634604, a Phase 3 study, was terminated before completion, sponsored by Jaeb Center for Health Research.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 16 participants
- Enrollment target
Study Summary
This randomized clinical trial will compare retinal outcomes with low-dose intravitreous bevacizumab (0.063 mg) versus laser photocoagulation as treatment for infants with type 1 retinopathy of prematurity (ROP). The study also will assess neurodevelopment, refractive error, visual acuity, and peripheral visual fields.
Interventions
- DRUG Bevacizumab
- PROCEDURE Laser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2022-04-27 |
| Est. Completion | 2023-08-14 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04634604
The ClinicalTrials.gov registry entry for NCT04634604 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jaeb Center for Health Research, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bevacizumab is the first listed.
NCT04634604 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04634604 about?
NCT04634604 is a clinical study titled "A Randomized Trial of Low-Dose Bevacizumab vs Laser for Type 1 ROP". This randomized clinical trial will compare retinal outcomes with low-dose intravitreous bevacizumab (0.063 mg) versus laser photocoagulation as treatment for infants with type 1 retinopathy of prematurity (ROP). The study also will assess neurodevelopment, refractive error, visual acuity, and peri...
What is the current status of trial NCT04634604?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 16 participants. The study started on 2022-04-27. Estimated completion is 2023-08-14.
What interventions are being tested in trial NCT04634604?
The interventions under investigation include: Bevacizumab (DRUG), Laser (PROCEDURE).
Who is sponsoring clinical trial NCT04634604?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.